Patents by Inventor Masami Inuma

Masami Inuma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210220338
    Abstract: The present invention provides a technique that allows a pharmaceutical composition, preferably for external use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCH2(CH2OCH2)nCH2OH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.
    Type: Application
    Filed: December 17, 2020
    Publication date: July 22, 2021
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Masahiro Ito, Kiyotaka Matsui, Masami Inuma
  • Publication number: 20210046052
    Abstract: The present invention provides a technique that allows a pharmaceutical composition, preferably for external use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCH2(CH2OCH2)nCH2OH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.
    Type: Application
    Filed: December 30, 2019
    Publication date: February 18, 2021
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Masahiro ITO, Kiyotaka MATSUI, Masami INUMA
  • Patent number: 10898470
    Abstract: The present invention provides a technique that allows a pharmaceutical composition, preferably for external use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCH2(CH2OCH2)nCH2OH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: January 26, 2021
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Masahiro Ito, Kiyotaka Matsui, Masami Inuma